Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
advocacy, aforementioned, alongside, anesthesia, appeal, arbitrarily, arbitrary, archived, artificial, asthma, AstraZeneca, attack, attorney, awaiting, Axalbion, bachelor, ballot, barzolvolimab, bearing, blocker, Boehringer, bolster, Bristol, broaden, built, camlipixant, capriciously, category, certiorari, cGCP, Chamber, channel, CIO, CMC, comment, compelled, conflicting, content, CORAL, cream, cyber, cybersecurity, Dakota, debating, destined, disaggregated, disposition, drip, electronic, embarrassment, engineering, entirety, eosinophilic, erasure, ethnicity, extinguishment, extrapolate, FASB, feedback, FTC, GABA, GABAB, gastroesophageal, GB, gefapixant, genetic, geopolitical, GERD, greatest, GSK, HAP, incontinence, Ingelheim, intelligence, Janssen, loosely, MA, MAs, mifepristone, moratorium, navigate, Nevada, NMDA, Nocion, Nordisk, North, Novo, occupied, oxygen, pack, PAM, password, pave, payoff, Pharma, phishing, PhRMA, plaintiff, plc, povorcitinib, premarket, prominently, PTA, QD, race, RCC, reactive, reflux, RIVER, ruxolitinib, sabotage, scavenger, simulated, sodium, sophisticated, sophistication, Squibb, stay, stayed, straightforward, stratification, strongly, sue, Switzerland, theft, topline, transposed, truthful, unbiased, uncompensated, uneven, unfair, unpermitted, upper, urinary, vivo, Washington, Windsor, Wisconsin, writ
Removed:
affirmative, assertion, attached, beta, choose, covenant, CT, deductibility, dermatological, disrupted, dissolving, economy, eudract, evolution, FFCR, fifty, flexibility, fulfill, GCP, HAL, halted, hereto, IEC, inseverable, interrupted, irrevocably, isolate, judge, Kiniksa, largest, lawful, lien, liquidating, main, marketer, minimize, modification, obligating, offshore, oncostatin, pharmacokinetic, planning, Plant, posting, prioritization, reassessed, recoverable, redirect, refundable, remote, repatriated, resuming, resurgence, retroactively, screening, Shionogi, spread, streamlined, subordinated, sustainability, temporarily, transferring, transitional, travel, unaffected, unclear, uncontrolled, unresolved, widespread, William
Filing tables
Filing exhibits
Related press release
Associated TRVI transcripts
TRVI similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1)
Registration Statements (Form S-3 Nos. 333-260279, 333-260820, 333-264614 and 333-273030) of Trevi Therapeutics, Inc.,
(2)
Registration Statement (Form S-8 No. 333-231260) pertaining to the 2012 Stock Incentive Plan, as amended, the 2019 Stock Incentive Plan and the 2019 Employee Stock Purchase Plan of Trevi Therapeutics, Inc., and
(3)
Registration Statements (Form S-8 Nos. 333-237193, 333-257729, 333-264615 and 333-271839) pertaining to the 2019 Stock Incentive Plan and the 2019 Employee Stock Purchase Plan of Trevi Therapeutics, Inc.;
of our report dated March 20, 2024, with respect to the consolidated financial statements of Trevi Therapeutics, Inc. included in this Annual Report (Form 10-K) of Trevi Therapeutics, Inc. for the year ended December 31, 2023.
/s/ Ernst & Young LLP
Hartford, Connecticut
March 20, 2024